Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Braz. arch. biol. technol ; 62: e19180556, 2019. tab, graf
Article in English | LILACS | ID: biblio-1019540

ABSTRACT

Abstract The objective of this work was to screen sweet cassava accessions collected in smallholding areas in the Midwestern, Southeastern and Southern regions of Brazil, using 15 SSR molecular markers, to determine population structure and genetic diversity. Polymorphism was detected in every loci analyzed, with mean of 6.33 alleles per locus, and mean polymorphism information content (PIC) of 0.6057, pointing out that the primers were highly informative. The observed heterozygosity ranged from 0.0709 (SSRY 101) to 0.9398 (GA 12), with a mean of 0.6511, and mean genetic diversity of 0.6578, ranging from 0.3592 (GA 136) to 0.8116 (SSRY 21). The most dissimilar combinations observed were BGM526PR-BGM596MS, BGM526PR-BGM622MS and BGM526PR-BGM629MS. The traditional cassava cultivars assessed were divided into four distinct groups: two with cultivars from the South, one from the Southeast and one from the Midwestern region of Brazil. The variances among and within groups determined by the analysis of molecular variance were 44 and 56%, respectively. The PhiPT parameter (analogue to Fst) of 0.44 indicates high differentiation among groups. Broad genetic diversity was found among the traditional sweet cassava cultivars assessed, and the most divergent groups were formed by cultivars from the South and the Midwestern regions of Brazil.


Subject(s)
Manihot/genetics , Seed Bank , Alleles , Hybridization, Genetic
2.
Rev. méd. Chile ; 144(7): 931-936, jul. 2016. ilus, tab
Article in Spanish | LILACS | ID: lil-794007

ABSTRACT

We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.


Subject(s)
Humans , Male , Adult , Bronchodilator Agents/adverse effects , HIV Infections/drug therapy , HIV Protease Inhibitors/adverse effects , Cushing Syndrome/chemically induced , Salmeterol Xinafoate/adverse effects , Fluticasone/adverse effects , Nebulizers and Vaporizers , Bronchodilator Agents/therapeutic use , HIV Protease Inhibitors/therapeutic use , Cushing Syndrome/diagnosis , Drug Interactions , Salmeterol Xinafoate/therapeutic use , Fluticasone/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL